First Time Loading...

LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 3.03 USD -2.26% Market Closed
Updated: May 4, 2024

LAVA Therapeutics NV
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LAVA Therapeutics NV
Cash from Financing Activities Peer Comparison

Comparables:
PHARM
QURE
ARGX
MRUS
N
NAMS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Cash from Financing Activities
-$571k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Cash from Financing Activities
-$1m
CAGR 3-Years
N/A
CAGR 5-Years
44%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Cash from Financing Activities
$362.7m
CAGR 3-Years
266%
CAGR 5-Years
18%
CAGR 10-Years
23%
argenx SE
XBRU:ARGX
Cash from Financing Activities
$1.3B
CAGR 3-Years
17%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Cash from Financing Activities
$230.1m
CAGR 3-Years
80%
CAGR 5-Years
30%
CAGR 10-Years
N/A
N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Cash from Financing Activities
€375.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is LAVA Therapeutics NV's Cash from Financing Activities?
Cash from Financing Activities
-571k USD

Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Cash from Financing Activities amounts to -571k USD.